CN110841070A - Silk fibroin-based material loaded with active ingredients and preparation and application thereof - Google Patents
Silk fibroin-based material loaded with active ingredients and preparation and application thereof Download PDFInfo
- Publication number
- CN110841070A CN110841070A CN201911201961.8A CN201911201961A CN110841070A CN 110841070 A CN110841070 A CN 110841070A CN 201911201961 A CN201911201961 A CN 201911201961A CN 110841070 A CN110841070 A CN 110841070A
- Authority
- CN
- China
- Prior art keywords
- silk fibroin
- freeze
- polyglutamic acid
- based material
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010022355 Fibroins Proteins 0.000 title claims abstract description 105
- 239000004480 active ingredient Substances 0.000 title claims abstract description 36
- 239000000463 material Substances 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 108010020346 Polyglutamic Acid Proteins 0.000 claims abstract description 38
- 229920002643 polyglutamic acid Polymers 0.000 claims abstract description 38
- 238000004108 freeze drying Methods 0.000 claims abstract description 32
- 239000000203 mixture Substances 0.000 claims abstract description 17
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 12
- 230000008014 freezing Effects 0.000 claims description 24
- 239000011259 mixed solution Substances 0.000 claims description 24
- 238000007710 freezing Methods 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 18
- 239000003963 antioxidant agent Substances 0.000 claims description 14
- 230000000975 bioactive effect Effects 0.000 claims description 12
- 230000003078 antioxidant effect Effects 0.000 claims description 7
- 238000009826 distribution Methods 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 4
- 230000003020 moisturizing effect Effects 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 3
- 230000036541 health Effects 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 18
- 230000003712 anti-aging effect Effects 0.000 abstract description 4
- 230000014759 maintenance of location Effects 0.000 abstract description 3
- 239000000686 essence Substances 0.000 description 45
- 239000000243 solution Substances 0.000 description 36
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 31
- 210000003491 skin Anatomy 0.000 description 27
- 239000000047 product Substances 0.000 description 23
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 20
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 16
- 229930003268 Vitamin C Natural products 0.000 description 16
- 239000006071 cream Substances 0.000 description 16
- 235000019154 vitamin C Nutrition 0.000 description 16
- 239000011718 vitamin C Substances 0.000 description 16
- 239000007788 liquid Substances 0.000 description 14
- 235000006708 antioxidants Nutrition 0.000 description 12
- 238000001816 cooling Methods 0.000 description 11
- 229910052757 nitrogen Inorganic materials 0.000 description 10
- 238000007493 shaping process Methods 0.000 description 9
- 239000007864 aqueous solution Substances 0.000 description 8
- 238000001035 drying Methods 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 238000004090 dissolution Methods 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 239000004005 microsphere Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 239000008223 sterile water Substances 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 239000002131 composite material Substances 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 239000003094 microcapsule Substances 0.000 description 4
- 239000002453 shampoo Substances 0.000 description 4
- 239000002893 slag Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000003607 modifier Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 2
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
- -1 correctant Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 235000003969 glutathione Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 235000002949 phytic acid Nutrition 0.000 description 2
- 229940068041 phytic acid Drugs 0.000 description 2
- 239000000467 phytic acid Substances 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000003223 protective agent Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 238000012876 topography Methods 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 240000004178 Anthoxanthum odoratum Species 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 238000005485 electric heating Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/88—Polyamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/84—Products or compounds obtained by lyophilisation, freeze-drying
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cosmetics (AREA)
Abstract
The invention relates to the use of a composition comprising silk fibroin and polyglutamic acid as a freeze-drying excipient. The silk fibroin plays a main role of freeze-drying excipient, and the polyglutamic acid plays an auxiliary role of the freeze-drying excipient; the molecular weight of the silk fibroin is distributed below 10 ten thousand Da, and the content of the silk fibroin is not lower than 50 percent; the content of polyglutamic acid is not less than 5%. The invention also discloses a preparation method of the silk fibroin-based material loaded with the active ingredient, and the silk fibroin-based material loaded with the active ingredient has the effects of silkiness, compactness, moisture retention and anti-aging after being used as a skin care product.
Description
Technical Field
The invention relates to the technical field of materials, in particular to a silk fibroin-based material loaded with active ingredients, and preparation and application thereof.
Background
In water, milk, cream and other aqueous cosmetics, antioxidants are added, and generally contain a plurality of active groups, and the active groups have different chemical instability tendencies, and chemical processes such as hydrolysis, enzymolysis and oxidation are frequently generated, so that the biological activity attribute of the antioxidants is lost. In addition, in water-based skin care products, in order to prevent the growth of microorganisms and to reasonably extend the shelf life of the product, preservatives are often added to the skin care products to ensure that the product does not deteriorate during use due to various contaminations. However, the preservative often has certain irritation, and long-term use of the skin care product containing the preservative can cause skin to be easily aged, reduce the oxidation resistance and the like, even cause allergy and lose the skin care function.
In recent years, a novel skin care product which is separated from dry skin and wet skin and represented by soluble collagen essence balls in Japan, longevity and nai, which not only maintains the safety and functionality of raw materials, but also improves the use convenience, appears on the market. But excipients were used in the preparation. Excipients often refer to binders and matrix supports added prior to pre-lyophilization to allow the sample to retain the shape of the molding die after lyophilization. The technology is widely applied to medicine freeze-drying, but is rarely applied to skin care products. The freeze-drying binder is generally artificial or natural high molecular polymer, inorganic substance gel, cellulose ethers, modified starch, dextran, chitosan, sodium alginate, PVP, PVA, polyethylene glycol, agar, polyamino acid, glycan or their combination. The components are not skin care functional components, so that the cost of the skin care product is increased and the safety is reduced. The Chinese patent CN 104198717B can obtain a spherical particle freeze-drying reagent for glucose detection by adding a freeze-drying protective agent and a plasticizer, and has the advantages of realization of stable storage at room temperature, transportation and the like compared with the existing liquid detection reagent. Chinese patent CN 105078783A uses 10-15% of trehalose, 10-15% of pullulan and 30-56% of mannitol as excipients to obtain a quick-dissolving collagen freeze-dried ball, and solves the problem of quick re-dissolving of collagen freeze-dried products.
The composition of Silk fibroin is similar to that of human keratin, the Silk fibroin HAs extremely strong affinity, safety and good biocompatibility with human skin, the Silk fibroin contains 18 amino acids, 11 of the components are required by human body, the activity of skin cells can be improved, skin aging is prevented and metabolism is promoted by effective supplement, the Silk fibroin HAs three different structural forms, namely Silk I, Silk II and Silk III, Silk I mainly comprise a-helical region mixed with a random coil and β -corner structure, the Silk fibroin is in a metastable state (a-helix domain, mixed with random coil and protein oil and β -turn structure, and water-soluble Silk II mainly comprises β -folded composition, HAs high stability, water-insoluble microsphere, the Silk III refers to an air-liquid interface and oil-water interface protein, CN 281A is added with a protective agent, 20-40% of a Silk fibroin, the Silk fibroin is a composite freeze-drying powder with a hydrophobic microcapsule, vitamin C is a composite freeze-drying powder with a hydrophobic protein microcapsule, vitamin C, a vitamin C is a composite freeze-drying powder with a hydrophobic microcapsule, a skin-protecting microcapsule, a vitamin C.
Therefore, how to prepare a skin care function by utilizing sufficient silk fibroin and prepare a freeze-dried material with a certain shape, particularly essence without using a freeze-dried excipient so that the freeze-dried material can be instantly dissolved in a water system to obtain an aqueous solution and can play a role of an active ingredient after being used is a technical problem to be solved urgently.
Disclosure of Invention
In order to solve the technical problems, the invention aims to provide the active ingredient loaded silk fibroin-based material and the preparation and application thereof.
The first objective of the present invention is to disclose the use of a composition comprising silk fibroin and polyglutamic acid as a freeze-drying excipient.
Further, in the composition, the mass fraction of the silk fibroin is not less than 50%, and the main molecular weight distribution of the silk fibroin is below 100 kDa.
Since the molecular weight distribution is wide, in order to describe the molecular weight range more precisely, in the present invention, the "molecular weight bulk distribution" refers to the "core region of the electrophoretic band", i.e., the molecular weight occupying more than 90% of the total silk fibroin fraction.
Further, in the composition, the mass fraction of the polyglutamic acid is not less than 5%, and the molecular weight of the polyglutamic acid is less than 100kDa, preferably 5-100 kDa.
In the composition, the silk fibroin plays a main role in freeze-drying excipient, the polyglutamic acid plays an auxiliary role in freeze-drying excipient, and meanwhile, the polyglutamic acid is beneficial to the quick dissolution of freeze-dried materials in various solutions.
The second purpose of the invention is to disclose a preparation method of silk fibroin-based material loaded with active ingredients, which comprises the following steps:
pouring a mixed solution containing polyglutamic acid, silk fibroin and bioactive components into a mould, and pre-freezing and forming, wherein the pre-freezing and forming conditions comprise that:
pre-freezing at-196 deg.C for more than 1 min; or
Pre-freezing for more than 2 hours at one or a combination of a plurality of temperatures of-5 to 80 ℃;
and then freeze-drying the pre-frozen and molded product with a certain geometric shape (non-powder shape) to obtain the silk fibroin-based material loaded with the active ingredient.
Further, the preparation method of the mixed solution containing polyglutamic acid, silk fibroin and bioactive components comprises the following steps:
respectively preparing polyglutamic acid aqueous solution and bioactive component solution, and then adding the polyglutamic acid aqueous solution and the bioactive component solution into the silk fibroin aqueous solution.
Further, in the mixed solution, the mass fraction of the silk fibroin is not less than 50%, and the main molecular weight distribution of the silk fibroin is below 100 kDa. The molecular weight of the silk fibroin is controlled by the conditions of degumming time, silk dissolving temperature and the like.
Further, in the mixed solution, the mass fraction of the polyglutamic acid is not less than 5%, and the molecular weight of the polyglutamic acid is less than 100kDa, preferably 5-100 kDa.
Further, the silk fibroin-based material loaded with active ingredients is essence, and the bioactive ingredients comprise moisturizing active ingredients except polyglutamic acid and an antioxidant; in the mixed solution, the mass fraction of the moisture-keeping active component is 0.01-20%, and the mass fraction of the antioxidant is 0.01-30%. The material containing moisture-keeping active ingredients and antioxidants has silky, compact, moisture-keeping and anti-aging effects after being used as a skin care product.
Preferably, the moisture-retaining active ingredient comprises one or more of hyaluronic acid, ceramide, synthetic polymer, collagen, glycerol and the like in any proportion.
Preferably, the antioxidant includes a synthetic antioxidant and a natural antioxidant. Artificial synthetic antioxidants such as BHA, BHT, PG, etc., and natural antioxidants such as tea polyphenols, phytic acid, SOD, glutathione, vitamin C, vitamin E, vitamin A, EGCG, coenzyme Q-10, etc.
Furthermore, the bioactive component also comprises one or a mixture of several of arbutin, tartaric acid, amino acid, polypeptide substances and the like in any proportion.
Preferably, the bioactive ingredient further comprises vitamin C.
Further, the mixed solution also comprises other auxiliary materials, including one or more of skin feel modifier, flavoring agent, essential oil, essence, trans-mucous membrane, transdermal absorption enhancer, pH regulator and the like.
Furthermore, because the pre-frozen product of the mixed solution is non-powdery, the silk fibroin-based material loaded with the active ingredients after freeze drying is not powdery in appearance, but has a certain geometric shape. These shapes include, but are not limited to, spherical, ellipsoidal, square, star, pentagram, circular, semi-circular, etc., and even combinations between different geometries.
Preferably, the prefreezing conditions include: directly dropping the mixed solution into liquid nitrogen (-196 ℃) for forming, wherein the pre-freezing time is not less than 1 minute; placing the mixed solution in a mould and then in a liquid nitrogen steam environment at (-196 ℃) for forming, wherein the pre-freezing time is not less than 1 minute; standing the mixed solution at a single constant temperature of-5 to-80 ℃ or in any combination environment among different temperatures for pre-freezing and forming, wherein the pre-freezing time at each temperature is not less than 2 hours; the mixed solutions are respectively stood in a freeze dryer with program temperature control, and the sample temperature is controlled by the freeze dryer program to be between-5 ℃ and-80 ℃ to be pre-frozen and formed in any combination environment. The pre-freezing step may also include a pre-cooling step at 2-8 deg.C for not less than 2 hr.
More preferably, the microdroplets are prepared by using a precisely quantifiable liquid separation system, and the microdroplets are dropped into liquid nitrogen and cooled by the liquid nitrogen to form the frozen reagent microspheres.
More preferably, the mixed solution is poured into a cavity of the forming die and cooled by liquid nitrogen to form a non-powdery solid with a certain geometric shape. The pre-freezing step may also include a pre-cooling step at 2-8 deg.C for not less than 2 hr.
More preferably, the mixed solution is poured into a forming mold cavity, and is cooled by liquid nitrogen steam (the temperature is-196 ℃) to form non-powdery solid with a certain geometric shape. The pre-freezing step may also comprise a pre-cooling step at 2-8 deg.C for not less than 2 hr
More preferably, the mixed solution is poured into a cavity of the forming die, and is cooled by a refrigerator (with a constant temperature of-5 to-80 ℃ or any combination of different temperatures) to form a non-powdery solid with a certain geometric shape. The pre-freezing step may also comprise a pre-cooling step at 2-8 deg.C for not less than 2 hr
More preferably, the mixed solution is poured into a cavity of the forming mold, and is subjected to gradient cooling by a pre-freezing program of a freeze dryer to form a non-powdery solid with a certain geometric shape. Freeze dryer prefreezing procedure the gradient cooling procedure was as follows: the mixed solutions are respectively stood in a freeze dryer with program temperature control, and the sample temperature is controlled by the freeze dryer program to be between-5 ℃ and-80 ℃ to be pre-frozen and formed in any combination environment. There is no vacuum. The pre-freezing step may also include a pre-cooling step at 2-8 deg.C for not less than 2 hr.
Further, before pre-freezing and forming, the method also comprises the step of pre-cooling for more than 2 hours at the temperature of 2-8 ℃.
Further, the freeze-drying mode comprises a non-temperature-control freeze-drying mode or a program freeze-drying mode, wherein the cold well temperature of the non-temperature-control freeze-drying mode is as follows: -45-80 ℃ and vacuum degree: 0.02-600 mBar, wherein the sample temperature is room temperature; the procedural freeze-drying mode comprises the following steps: -45 to-80 ℃, the sample temperature is-50 to 40 ℃, and the vacuum degree is 0.02 to 600 mBar. The sample temperature and vacuum were automatically controlled by the lyophilizer program. The freeze-drying time is comprehensively set according to the unit time deicing amount of the freeze dryer and the machine loading amount of the sample.
The third purpose of the invention is to protect the silk fibroin-based material loaded with active ingredients prepared by the preparation method.
The silk fibroin-based material loaded with active ingredients prepared by the method of the present invention is preferably essence which can be dissolved in face wash, bath lotion, shampoo, lotion, perfume, skin cleanser, makeup remover, essence, stock solution, sterile water, honey emulsion, milk emulsion, hair care emulsion, essence emulsion, moisturizing cream, foundation cream, shampoo, concealer, hair treatment cream, essence cream, pre-makeup cream, etc.
The invention also discloses application of the silk fibroin-based material loaded with the active ingredients in the field of preparation of skin care products, health care products, foods, medicines or medical appliances.
Furthermore, the silk fibroin-based material loaded with the active ingredients has the effects of silkiness, compactness, moisture retention and anti-aging after being used as a skin care product.
By the scheme, the invention at least has the following advantages:
the invention discloses a novel freeze-dried excipient composition, which comprises silk fibroin and polyglutamic acid. The silk fibroin-based material loaded with active ingredients can be prepared by utilizing the two materials, is non-powdery and easily soluble in water, can quickly release the active ingredients in the material, and has wide application prospect in the fields of skin care products, health care products, foods, medicines or medical devices.
The foregoing description is only an overview of the technical solutions of the present invention, and in order to make the technical solutions of the present invention more clearly understood and to implement them in accordance with the contents of the description, the following detailed description is given with reference to the preferred embodiments of the present invention and the accompanying drawings.
Drawings
FIG. 1 is an SDS-PAGE electrophoresis of silk fibroin;
FIG. 2 is a graph showing the effect of reconstitution of lyophilized silk fibroin essence in water;
fig. 3 is an external view of freeze-dried silk fibroin essences of various shapes prepared in examples 1 to 4 of the present invention;
fig. 4 is a graph showing rapid dissolution of active ingredient-loaded silk fibroin lyophilized material in a cream-type daily chemical product;
fig. 5 is a topography of different silk fibroin lyophilized materials before and after water vapor treatment.
Detailed Description
The following detailed description of embodiments of the present invention is provided in connection with the accompanying drawings and examples. The following examples are intended to illustrate the invention but are not intended to limit the scope of the invention.
Example 1: preparation of freeze-dried silk fibroin essence
(1) Weighing 250 g of raw silk of domestic silkworm, cutting silk fiber, and the length of each section is about 15 cm. Heating 100 liters of pure water by using an electric heating tank, slowly adding 212 grams of anhydrous sodium carbonate when the pure water is heated to be nearly boiled, uniformly stirring, continuously heating until the pure water is boiled, adding raw silk, starting timing when the raw silk is completely immersed in water, stirring once every 7 minutes, respectively boiling for 30 minutes, 45 minutes, 60 minutes, 90 minutes and 120 minutes, and then taking out. Placing degummed silk into a washing machine, setting a rinsing program, washing twice by using pure water, and placing the dehydrated degummed silk into a forced air drying oven to be dried for 12-18 hours.
(2) Preparing 9.3M lithium bromide solution, adding degummed silk according to the bath ratio of the degummed silk to the lithium bromide solution 1/4, dissolving for 4 hours in a drying box with the temperature of 60 ℃, taking out, cooling to room temperature, filling the dissolved silk fibroin solution into a dialysis bag with the molecular weight cutoff of 3500, dialyzing for 48 hours with pure water, and changing water for 6 times. And filtering the dialyzed silk fibroin solution by using 5 layers of gauze to remove impurities, and placing the silk fibroin solution in a refrigerated cabinet at the temperature of 2-8 ℃ for later use. And simultaneously determining the mass fraction of the silk fibroin by using a drying and weighing method. The molecular weight of the silk fibroin processed in the step (2) is determined by SDS-PAGE, the molecular weight of the silk fibroin indicated by degumming time of 90min is listed in figure 1, and the main body of the silk fibroin is distributed below 100 kDa.
(3) And (3) further preparing the silk fibroin processed in the step (2) into a 5% (wt/V) silk fibroin solution by using deionized water.
(4) Preparing 0.36g/mL vitamin C water solution.
(5) An aqueous solution of polyglutamic acid having a molecular weight of about 100kDa at a concentration of 0.24g/mL was prepared.
(6) Mixing the vitamin C aqueous solution and the polyglutamic acid aqueous solution prepared in the steps (4) and (5) with the silk fibroin solution according to the volume ratio of 1: 1: 10, mixing and stirring uniformly.
(7) The liquid separation system capable of accurately quantifying is utilized to prepare micro-droplets, the shapes of the droplets are various, the droplets are dripped into liquid nitrogen, and the frozen reagent microspheres are formed after the droplets are cooled by the liquid nitrogen.
(8) The frozen reagent microspheres were non-lyophilized. And (3) obtaining the freeze-dried silk fibroin essence by cold trap temperature of not higher than-55 ℃ and vacuum degree of not higher than 0.05 mBar.
(9) The subjects respectively take 25 mg of freeze-dried silk fibroin essence to the palms and add 1.5mL of sterile water. As a result, as shown in fig. 2, it can be seen that the lyophilized silk fibroin essence of the present invention can be reconstituted in water, and the solution is clear. The essence aqueous solution was uniformly wiped on the face, and the subjects continuously used for 8 weeks for moisture retention and anti-aging effect evaluation.
A subject: 100 women without skin sensitivity history and aged 25-40 years, wherein the test product is randomly used by a volunteer on one half face and the other half face is blank during the test period; and randomly and evenly distributing freeze-dried silk fibroin essence prepared from silk fibroin with degumming time of 30min, 45min, 60min, 90min and 120min to 100 subjects, namely 20 subjects in each composite microsphere freeze-dried powder.
The using method comprises the following steps: the freeze-dried silk fibroin essence prepared from silk fibroin with different degumming time is redissolved to obtain a solution, and the solution is uniformly smeared on the face and is used once a day in the morning and at night. The application is continued for 8 weeks.
And (4) recording return visits: the evaluation statistics of the compact and silky effects are shown in tables 1 and 2, wherein the test subjects are revisited after 8 weeks, and the test subjects are queried and recorded for the effect of the use.
Table 1 evaluation of tightening effect of lyophilized silk fibroin essence prepared from silk fibroin having different molecular weights
Table 2 evaluation of silky slipping effect of lyophilized silk fibroin essence prepared from silk fibroin having different molecular weights
Example 2: preparation of freeze-dried silk fibroin essence
(1) The silk fibroin solution was prepared according to the method of example 1, steps (1) to (3), wherein the degumming time was 90 min.
(2) A mixed solution of vitamin C, polyglutamic acid and silk fibroin was prepared according to the method of steps (4) to (6) of example 1.
(3) Pouring the mixed solution into a cylindrical, heart-shaped, disc, semicircle or square die, and pre-freezing and forming by liquid nitrogen or nitrogen (the temperature is-196 ℃).
(4) And (5) freeze-drying the program. A main drying stage: the temperature is increased to minus 20 ℃, the temperature is 0.2 ℃ per minute, the vacuum degree is 100mTorr, and the temperature is maintained for 2400 minutes; final drying stage: the temperature was raised to 4 deg.C, 0.2 deg.C per minute, and the vacuum was maintained at 100mTorr for 620 minutes.
Example 3: preparation of freeze-dried silk fibroin essence
Lyophilized silk fibroin essence was prepared according to the method of example 2, except that, in the step (3), pre-freezing molding was performed using a refrigerator, the freezing temperature of which was-80 ℃.
Example 4: preparation of freeze-dried silk fibroin essence by programmed pre-freezing method
The lyophilized silk fibroin essence was prepared according to the method of example 2, except that in the step (3), a programmed pre-freezing method was adopted, and the specific steps were as follows: the mixed solution is poured into a cylinder, a heart-shaped mold, a disc, a semicircle and a square mold, the mold is placed in a freeze dryer, and the pre-freezing program is formed by gradient cooling: the temperature is changed from room temperature to-45 ℃, the temperature is quickly recorded at 0.1 ℃ per minute, and the maintaining time is 480 minutes.
Fig. 3 is a photograph of lyophilized silk fibroin essences of various shapes, which can be cylindrical, circular, spheral, square, heart-shaped, etc., prepared in examples 1 to 4 of the present invention.
Example 5: preparation of freeze-dried silk fibroin essence carrying active ingredients
(1) The silk fibroin solution was prepared according to the method of example 1, steps (1) to (3), wherein the degumming time was 90 min.
(2) Vitamin C and polyglutamic acid solutions were prepared in the same manner as in steps (4) to (5) of example 1. In addition, a solution of bioactive components is prepared, such as synthetic antioxidants (e.g. BHA, BHT, PG, etc.), natural antioxidants (e.g. tea polyphenols, phytic acid, SOD, glutathione, vitamin C, vitamin E, vitamin A, EGCG, coenzyme Q-10, etc.), arbutin, tartaric acid, amino acid solution. Preparing moisture-keeping active ingredient solution, such as hyaluronic acid, ceramide, synthetic polymer, collagen protein, and glycerol solution.
(3) Adding polyglutamic acid solution, bioactive component solution, and moisture keeping active component solution into silk fibroin solution, adding skin feeling modifier, correctant, essential oil, essence, trans-mucosa, transdermal absorption enhancer and pH regulator, and mixing. Wherein the silk fibroin accounts for 50% of the total dry weight of the raw materials of the mixture, the polyglutamic acid accounts for 20% of the total dry weight of the raw materials of the mixture, the total sum of the bioactive components accounts for 20% of the total dry weight of the raw materials of the mixture, the total sum of the moisture-preserving active components accounts for 9% of the total dry weight of the raw materials of the mixture, and the total sum of the skin feel modifier, the flavoring agent, the essential oil and the essence, the trans-mucous membrane, the transdermal absorption.
(4) The mixed solution is poured into a cylinder, a heart-shaped mold, a disc, a semicircle and a square mold, the mold is placed in a freeze dryer, and the pre-freezing program is formed by gradient cooling: the temperature is changed from room temperature to-45 ℃, the temperature is quickly recorded at 0.1 ℃ per minute, and the maintaining time is 480 minutes.
(5) And (5) freeze-drying the program. A main drying stage: the temperature is increased to minus 20 ℃, the temperature is 0.2 ℃ per minute, the vacuum degree is 100mTorr, and the temperature is maintained for 2400 minutes; final drying stage: the temperature is raised to 4 ℃, the temperature is 0.2 ℃ per minute, the vacuum degree is 100mTorr, and the temperature is maintained for 620 minutes, so that the freeze-dried silk fibroin essence carrying the active ingredients is obtained. The obtained product is integrated, does not drop slag, does not have scraps, and has a full shape and a smooth surface.
The prepared freeze-dried silk fibroin essence carrying the active ingredients can be respectively dissolved in liquid: face washing lotion, bath lotion, shampoo, cosmetic water, perfume, skin cleaning water, makeup remover, essence, stock solution, sterile water, etc.; emulsion: honey, milk, hair care cream, essence cream; creams and ointments: moisturizing cream, foundation cream, shampoo, concealer, hair treatment cream, essence cream, pre-makeup cream, etc. Fig. 4 is a diagram showing that the freeze-dried silk fibroin essence carrying the active ingredient can be rapidly dissolved in the cream type daily chemical products, and the freeze-dried silk fibroin essence carrying the active ingredient can be dissolved in the cream type daily chemical products within 1 minute.
The prepared freeze-dried silk fibroin essence carrying the active ingredient is added into 10mL of sterile water, and the obtained freeze-dried silk fibroin essence is rapidly disintegrated, completely dissolved, free of particles and free of agglomeration.
Placing the prepared freeze-dried silk fibroin essence carrying the active ingredient in a palm, adding about 1mL of sterile water, gently kneading uniformly, then applying the obtained product on the face, drying, and then ensuring smooth and firm feeling without residue or debris.
Example 6: preparation of freeze-dried silk fibroin essence carrying active ingredients
(1) A Silk fibroin (Silk) solution was prepared according to the method of steps (1) to (3) of example 1, wherein the degumming time was 90 min.
(2) A50 mg/mL Vitamin C (VC) solution and a 50mg/mL polyglutamic acid (PGA) solution were prepared.
(6) The silk fibroin solution, the vitamin C solution and the polyglutamic acid solution are mixed according to different proportions, and the statistics of the shaping effect, the solubility, the shaping effect after water vapor treatment, the skin feel grade evaluation and the like of the freeze-dried essence corresponding to the final proportions of the silk fibroin solution, the vitamin C solution and the polyglutamic acid solution are shown in table 3.
In table 3, the dry state shaping effect is classified into 1, 2, and 3: wherein the grade 1 is a whole body after freeze-drying, has no scraps and broken slag, is full in shape and has a smooth surface; the 2 level is that partial chip falling or slag crushing phenomenon exists; the grade 3 shows that the chips or the slag are much, the shape is shrivelled and the shape is basically not formed. The solubility is divided into 1, 2 and 3 grades: wherein the 1 grade is that the complete dissolution time is within 1 minute; the 2 grade is that the complete dissolution time is more than 1 minute and less than 15 minutes; the complete dissolution time of grade 3 is 15 minutes or more. The shaping effect after the water vapor treatment is divided into 1, 2 and 3 grades: wherein, the grade 1 is that the original shape is still kept after the water vapor treatment; the 2-stage is that the original shape is basically kept after the water vapor treatment, and the shrinkage is slight; the grade 3 is that the original shape can not be maintained at all, and the shrinkage phenomenon is serious. The skin feel grades are comprehensively evaluated in combination with the silky and compact effects and are divided into 1, 2 and 3 grades: wherein level 1 is very comfortable; level 2 is more comfortable; level 3 is uncomfortable; "-" indicates no statistics.
TABLE 3 statistics of the shaping effect and skin feel of lyophilized silk fibroin essence with different components
As shown in Table 3, silk fibroin occupies 50% or more of the mass of the mixture to have a good shaping effect, and the shaping effect can be still maintained after steam treatment when the content of polyglutamic acid is more than 5%, and the skin feel is the best when the content of silk fibroin is 50% -70%, the content of polyglutamic acid is more than 5%, and the content of VC is less than 30%, and the skin feel is not counted because the formability is poor in the rest addition ratios.
In order to prove the auxiliary shaping effect of the polyglutamic acid, the appearance of the essence ball after water vapor treatment is used as an evaluation item of the shaping effect. Fig. 5 is a topography of the essence balls No. 1 and No. 3 in table 3 before and after water vapor treatment, respectively, and the results show that the appearance of the pure silk fibroin (fig. 5a) and the appearance of the essence ball added with polyglutamic acid (fig. 5b) after freeze-drying are not obviously different, but the pure silk fibroin ball is reduced after water vapor treatment, the overall shape is still spherical, but a large number of pointed structures appear on the edge (fig. 5 c); the whole ball is still spherical after the polyglutamic acid essence ball is added, the edge is clear, and the ball is complete (figure 5 d).
The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention, it should be noted that, for those skilled in the art, many modifications and variations can be made without departing from the technical principle of the present invention, and these modifications and variations should also be regarded as the protection scope of the present invention.
Claims (10)
1. Use of a composition comprising silk fibroin and polyglutamic acid as a freeze-drying excipient.
2. Use according to claim 1, characterized in that: in the composition, the mass fraction of the silk fibroin is not less than 50%, and the main molecular weight distribution of the silk fibroin is below 100 kDa.
3. Use according to claim 1, characterized in that: in the composition, the mass fraction of the polyglutamic acid is not less than 5%, and the molecular weight of the polyglutamic acid is less than 100 kDa.
4. A preparation method of a silk fibroin-based material loaded with active ingredients is characterized by comprising the following steps:
pre-freezing and forming a mixed solution containing polyglutamic acid, silk fibroin and bioactive components, wherein the pre-freezing and forming conditions comprise that:
pre-freezing at-196 deg.C for more than 1 min; or
Pre-freezing for more than 2 hours at one or a combination of a plurality of temperatures of-5 to 80 ℃;
and then freeze-drying the non-powdery pre-frozen molded product to obtain the silk fibroin-based material loaded with the active ingredient.
5. The method of claim 4, wherein: in the mixed solution, the mass fraction of silk fibroin is not less than 50%, and the main molecular weight distribution of the silk fibroin is below 100 kDa.
6. The method of claim 4, wherein: in the mixed solution, the mass fraction of the polyglutamic acid is not less than 5%, and the molecular weight of the polyglutamic acid is less than 100 kDa.
7. The method of claim 4, wherein: the silk fibroin-based material loaded with the active ingredients is essence, and the bioactive ingredients comprise moisturizing active ingredients except polyglutamic acid and an antioxidant; in the mixed solution, the mass fraction of the moisture-keeping active component is 0.01-20%, and the mass fraction of the antioxidant is 0.01-30%.
8. The method of claim 4, wherein: the freeze-drying mode comprises a non-temperature-control freeze-drying mode or a program freeze-drying mode, wherein the cold well temperature of the non-temperature-control freeze-drying mode is as follows: -45-80 ℃ and vacuum degree: 0.02-600 mBar, wherein the sample temperature is room temperature; the procedural freeze-drying mode comprises the following steps: -45 to-80 ℃, the sample temperature is-50 to 40 ℃, and the vacuum degree is 0.02 to 600 mBar.
9. An active ingredient-loaded silk fibroin-based material prepared by the preparation method of any one of claims 1-8.
10. Use of the active ingredient loaded silk fibroin-based material of claim 9 in the field of preparation of skin care products, health products, foods, pharmaceuticals or medical devices.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911201961.8A CN110841070A (en) | 2019-11-29 | 2019-11-29 | Silk fibroin-based material loaded with active ingredients and preparation and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911201961.8A CN110841070A (en) | 2019-11-29 | 2019-11-29 | Silk fibroin-based material loaded with active ingredients and preparation and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110841070A true CN110841070A (en) | 2020-02-28 |
Family
ID=69606345
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911201961.8A Pending CN110841070A (en) | 2019-11-29 | 2019-11-29 | Silk fibroin-based material loaded with active ingredients and preparation and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110841070A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113576944A (en) * | 2021-08-09 | 2021-11-02 | 中山中研化妆品有限公司 | Freeze-dried ball and preparation method thereof and skin care product |
| CN114903809A (en) * | 2021-02-08 | 2022-08-16 | 李和伟 | Single-matrix freeze-dried excipient, preparation method thereof and freeze-dried preparation for beautifying and protecting skin |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103965491A (en) * | 2014-04-21 | 2014-08-06 | 浙江大学 | Preparation method for silk fibroin composite gel |
| US20150094262A1 (en) * | 2012-04-25 | 2015-04-02 | Hitachi Chemical Company, Ltd. | Sustained release carrier for drugs |
| US20160046679A1 (en) * | 2013-03-15 | 2016-02-18 | Trustees Of Tufts College | Low molecular weight silk compositions and stabilizing silk compositions |
| CN108478527A (en) * | 2018-04-19 | 2018-09-04 | 中原工学院 | A kind of Preparation method and use of sericin and gamma-polyglutamic acid self-assembly nano-micelle |
| CN108642878A (en) * | 2018-04-19 | 2018-10-12 | 中原工学院 | A method of arranging polyester fabric using fibroin albumen and gamma-polyglutamic acid self-assembly |
-
2019
- 2019-11-29 CN CN201911201961.8A patent/CN110841070A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150094262A1 (en) * | 2012-04-25 | 2015-04-02 | Hitachi Chemical Company, Ltd. | Sustained release carrier for drugs |
| US20160046679A1 (en) * | 2013-03-15 | 2016-02-18 | Trustees Of Tufts College | Low molecular weight silk compositions and stabilizing silk compositions |
| CN103965491A (en) * | 2014-04-21 | 2014-08-06 | 浙江大学 | Preparation method for silk fibroin composite gel |
| CN108478527A (en) * | 2018-04-19 | 2018-09-04 | 中原工学院 | A kind of Preparation method and use of sericin and gamma-polyglutamic acid self-assembly nano-micelle |
| CN108642878A (en) * | 2018-04-19 | 2018-10-12 | 中原工学院 | A method of arranging polyester fabric using fibroin albumen and gamma-polyglutamic acid self-assembly |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114903809A (en) * | 2021-02-08 | 2022-08-16 | 李和伟 | Single-matrix freeze-dried excipient, preparation method thereof and freeze-dried preparation for beautifying and protecting skin |
| CN113576944A (en) * | 2021-08-09 | 2021-11-02 | 中山中研化妆品有限公司 | Freeze-dried ball and preparation method thereof and skin care product |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7776545B2 (en) | Silk protein fragment compositions and articles made therefrom | |
| CN103355679B (en) | Making method of chewable tablet with effect of enriching blood | |
| CN101889958A (en) | Freeze-dried composition | |
| KR101754305B1 (en) | Instant cooling facial mask manufacturing method of composition and cooling facial mask | |
| HK1217287A1 (en) | Freeze-dried composition of active substance | |
| KR101723845B1 (en) | Natural cosmetic composition of mask pack and method for manufacturing natural cosmetic composition of mask pack | |
| US12280136B2 (en) | Compositions containing exosomes from animal placenta, methods for producing the same and uses thereof | |
| JP2023138656A (en) | Foaming skin topical preparation | |
| CN110464658B (en) | Multi-effect eye freeze-dried film and steam eye-shade | |
| CN102920646A (en) | Nourishing moisture-retention emulsion and preparation method thereof | |
| CN107157880A (en) | A kind of HERBA DENDROBII moisturizing sleep mask and preparation method thereof | |
| US20100272834A1 (en) | Freeze-Dried Molded Article Containing Magnesium Ascorbyl Phosphate | |
| CN109395056A (en) | A kind of crease-resistant class preparation for external application to skin and preparation method and application | |
| CN102429852A (en) | Preparation method for processing freckle-removing and beautifying ultrafine powder by using peach blossom | |
| CN110841070A (en) | Silk fibroin-based material loaded with active ingredients and preparation and application thereof | |
| CN114917134B (en) | Freeze-dried composition containing skeleton molecules and liposome embedding and application thereof | |
| CN108112994A (en) | A kind of rose collagen broken wall composition and its preparation method and application | |
| CN114886785B (en) | Ternary freeze-dried composition and application thereof in freeze-dried preparation | |
| CN110755298B (en) | Freeze-dried oral care composition and application thereof | |
| CN108042651A (en) | A kind of sub- broken wall composition of chrysanthemum medlar and its preparation method and application | |
| CN115429733A (en) | Plant extraction and drying process and application thereof | |
| CN103417573B (en) | Method for preparing deer skin gelatin freeze-dried powder | |
| CN109350592B (en) | Pure natural egg white mask and preparation method thereof | |
| CN105616323A (en) | Silk sponge product for nourishing and caring skin and preparation method thereof | |
| CN101260359B (en) | Process for preparing peach blossom wine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200228 |


